Getagraph.com logo
S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Sanntidsoppdatering for Cantargia AB (publ) [CANTA.ST]

Børs: STO Sektor: Healthcare Industri: Biotechnology
Sist oppdatert3 mai 2024 @ 17:29
25% discount on Stockinvest.us - Use code: Podcast

5.43% SEK 3.42

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 17:29):

Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the tumor inflammation that is driven by the Interleukin-1 system and is under phase IIa clinical trial; and CAN10, an antibody against IL1RAP for treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis, and is under preclinical trial...

Stats
Dagens volum 187 738
Gjennomsnittsvolum 570 691
Markedsverdi 570.76M
EPS SEK0 ( 2024-02-21 )
Neste inntjeningsdato ( SEK0 ) 2024-05-21
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -1.540
ATR14 SEK0.00500 (0.15%)

Volum Korrelasjon

Lang: -0.14 (neutral)
Kort: -0.54 (weak negative)
Signal:(47.564) Neutral

Cantargia AB (publ) Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Cantargia AB (publ) Korrelasjon - Valuta/Råvare

The country flag 0.10
( neutral )
The country flag 0.11
( neutral )
The country flag 0.00
( neutral )
The country flag 0.16
( neutral )
The country flag -0.47
( neutral )
The country flag -0.26
( neutral )

Cantargia AB (publ) Økonomi

Annual 2023
Omsetning: SEK0
Bruttogevinst: SEK-3.45M (0.00 %)
EPS: SEK-1.650
FY 2023
Omsetning: SEK0
Bruttogevinst: SEK-3.45M (0.00 %)
EPS: SEK-1.650
FY 2022
Omsetning: SEK0
Bruttogevinst: SEK-3.69M (0.00 %)
EPS: SEK-2.83
FY 2021
Omsetning: SEK0.00
Bruttogevinst: SEK0.00 (0.00 %)
EPS: SEK-3.05

Financial Reports:

No articles found.

Cantargia AB (publ)

Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the tumor inflammation that is driven by the Interleukin-1 system and is under phase IIa clinical trial; and CAN10, an antibody against IL1RAP for treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis, and is under preclinical trial. It is also developing CANxx antibodies against IL1RAP. The company has collaboration agreements with Patheon Biologics BV and BioWa Inc. for the manufacture and production of CAN04; and Specialized Medical Services-oncology BV for the clinical study of CAN04. Cantargia AB (publ) was founded in 2010 and is based in Lund, Sweden.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.